The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Evaluating CR as a surrogate endpoint for PFS in R/R chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL): A meta-analysis of randomized controlled trials (RCT).
 
Lin Wang
Employment - Bristol-Myers Squibb
Stock and Other Ownership Interests - Bristol-Myers Squibb
 
Tim Disher
Employment - Eversana
 
Fei Fei Liu
Employment - Bristol Myers Squibb Foundation
Stock and Other Ownership Interests - Bristol-Myers Squibb
 
Murat Kurt
Employment - Bristol-Myers Squibb
Stock and Other Ownership Interests - Bristol-Myers Squibb
Travel, Accommodations, Expenses - Bristol-Myers Squibb
 
Serena K. Perna
Employment - BMS Brazil
Stock and Other Ownership Interests - Autolus; Bristol-Myers Squibb
Honoraria - Bristol-Myers Squibb
 
Elise Aronitz
Employment - EVERSANA
 
Toby A. Eyre
Honoraria - Abbvie; AstraZeneca/MedImmune; Autolus Therapeutics; Gilead Sciences; Incyte; Janssen Oncology; Loxo/Lilly; Roche; Secura Bio
Consulting or Advisory Role - Abbvie; AstraZeneca/MedImmune; BeiGene; Incyte; Kite/Gilead; Loxo; Roche; Secura Bio
Research Funding - AstraZeneca/MedImmune; BeiGene
 
Matthew Steven Davids
Honoraria - Aptitude Health; Axis Medical Education; Bio Ascend; Curio Science; Medscape; Peerview; Physicans' Education Resource; PlatformQ Health; Plexus; Research to Practice
Consulting or Advisory Role - Abbvie; Adaptive Biotechnologies; Ascentage Pharma; AstraZeneca; BeiGene; Bristol-Myers Squibb; Genentech; Genmab; Janssen; Lilly; MEI Pharma; Merck; MingSight; Nuvalent, Inc.; Secura Bio; Takeda; TG Therapeutics
Research Funding - AbbVie (Inst); Ascentage Pharma (Inst); AstraZeneca (Inst); Genentech (Inst); Novartis (Inst); Secura Bio (Inst); TG Therapeutics (Inst)
Patents, Royalties, Other Intellectual Property - Up-to-date royalties